EBS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $6.33

Piyasa Değeri (MRQ) $325M

P/E (TTM) -1.8

Hisse Başına Kâr (TTM) $-3.46

Gelir (TTM) $770M

ROE (TTM) -40.3%

D/E Borç/Özsermaye (MRQ) 1.7

52 Haftlık Aralık $4–$14

EBS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$743M

2017-12-31 → 2025-12-31

Hisse Başına Kâr$0.93

2017-12-31 → 2025-12-31

Serbest Nakit Akışı$157M

2017-12-31 → 2025-12-31

Net kar marjı-23.0%

2017-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	EBS	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-1.85Y ort. ≈1.9	≈1.9	·	·
F/S (TTM)	0.45Y ort. ≈0.5	≈0.5	25.7	Düşük değerli
F/D (MRQ)	1.05Y ort. ≈0.8	≈0.8	2.5	Düşük değerli
EV / EBITDA	3.65Y ort. ≈3612.0	≈3612.0	·	·
Fiyat / Serbest Nakit Akışı (TTM)	3.85Y ort. ≈6.0	≈6.0	·	·
Fiyat / Nakit Akışı (TTM)	3.35Y ort. ≈4.0	≈4.0	·	·
EV / Revenue (EV / Gelir)	0.95Y ort. ≈1.2	≈1.2	·	·
EV / FCF	4.45Y ort. ≈10.6	≈10.6	·	·
Fiyat / Maddi Defter Değeri (MRQ)	4.15Y ort. ≈3.4	≈3.4	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	EBS	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-8.6%5Y ort. ≈-20.3%	≈-20.3%	-209.1%	En üst düzey
FAVÖK Marjı (TTM)	3.7%5Y ort. ≈-11.5%	≈-11.5%	-209.1%	En üst düzey
Vergi Öncesi Kar Marjı (TTM)	-19.0%5Y ort. ≈-23.0%	≈-23.0%	-245.7%	En üst düzey
Net Kâr Marjı (TTM)	-23.0%5Y ort. ≈-25.7%	≈-25.7%	-246.0%	En üst düzey
ROA (TTM)	-14.0%5Y ort. ≈-12.8%	≈-12.8%	-49.3%	En üst düzey
ROE (TTM)	-40.3%5Y ort. ≈-47.2%	≈-47.2%	-64.8%	En üst düzey
ROIC	5.8%5Y ort. ≈-15.4%	≈-15.4%	-100.1%	En üst düzey

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	EBS	5Y ort.	Akran Ortalaması	Sonuç
Borç / Öz Sermaye (MRQ)	1.75Y ort. ≈1.5	≈1.5	·	·
Cari Oran (MRQ)	5.45Y ort. ≈3.2	≈3.2	5.1	Aynı seviyede
Quick Ratio (Cari Oran)	2.25Y ort. ≈1.4	≈1.4	2.9	Düşük likidite
Uzun Vadeli Borç / Özkaynak (MRQ)	1.75Y ort. ≈1.1	≈1.1	·	·

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	EBS	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	-28.8%5Y ort. ≈-18.1%	≈-18.1%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	-12.7%5Y ort. ≈-13.9%	≈-13.9%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	-14.0%	·	·	·
EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y)	-30.4%	·	·	·
Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y)	-29.7%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	EBS	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$0.935Y ort. ≈$-5.43	≈$-5.43	·	·
Revenue / Share (Hisse Başına Gelir)	$13.105Y ort. ≈$18.90	≈$18.90	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$3.015Y ort. ≈$-0.15	≈$-0.15	·	·
Cash / Share (Hisse Başına Nakit)	$3.945Y ort. ≈$2.64	≈$2.64	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	EBS	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.55Y ort. ≈0.5	≈0.5	0.1	En üst düzey
Inventory Turnover (Stok Devir Hızı)	1.0	·	·	·
Receivables Turnover (Alacak Devir Hızı)	6.25Y ort. ≈6.1	≈6.1	2.6	En üst düzey
Revenue / Employee (Çalışan Başına Gelir)	≈$825.4K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 217.1%

Sonraki Rapor Eki 27, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 11, 2026	$0.60	$0.11	440.1%
31 Mart 2026	May 13, 2026	$0.21	$-0.25	183.2%
31 Aralık 2025		$-0.43	$0.11	-487.0%
30 Eylül 2025		$1.06	$-0.12	974.6%
30 Haziran 2025		$0.16	$-0.49	132.3%
31 Mart 2025		$0.71	$0.44	59.8%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 18

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$743M	$1.04B	$1.05B	$1.12B	$1.77B	$1.58B	$1.11B	$782M	$561M	$489M	$489M	$404M
Cost of Revenue	$326M	$681M	$705M	$693M	$748M	$537M	$434M	$322M	$188M	$126M	$107M	$102M
Gross Profit	·	·	$318M	$383M	$891M	$925M	·	·	·	·	·	·
R&D Expense	$53M	$71M	$111M	$188M	$235M	$238M	$226M	$143M	$97M	$107M	$119M	$105M
SG&A Expense	$186M	$308M	$368M	$340M	$349M	$304M	$274M	$202M	$143M	$143M	$121M	$109M
Operating Expenses	·	·	·	·	·	·	$992M	$693M	$437M	$383M	·	·
Operating Income	$100M	$-109M	$-726M	$-170M	$341M	$438M	$114M	$90M	$124M	$106M	$142M	$89M
Interest Expense	·	·	$88M	$37M	$34M	$31M	$38M	$10M	$7M	$8M	$7M	$8M
Interest Income	·	·	·	·	·	·	·	·	$2M	$1M	$572.0K	$320.0K
Other Non-op	$54M	$12M	$6M	$-12M	$-4M	$5M	$2M	$2M	$900.0K	$1M	$153.0K	$3M
Pretax Income	$83M	$-143M	$-731M	$-219M	$303M	$412M	$77M	$82M	$119M	$99M	$136M	$84M
Income Tax	$30M	$48M	$29M	$-7M	$84M	$106M	$23M	$19M	$36M	$37M	$44M	$30M
Net Income	$53M	$-191M	$-760M	$-212M	$220M	$306M	$54M	$63M	$83M	$52M	$63M	$37M
EPS (Basic)	$0.98	$-3.60	$-14.85	$-4.22	$4.10	$5.80	$1.06	$1.25	$1.98	$1.29	$1.63	$0.98
EPS (Diluted)	$0.93	$-3.60	$-14.85	$-4.22	$4.06	$5.68	$1.04	$1.22	$1.71	$1.13	$1.41	$0.88
Shares (Basic)	53,500,000	53,000,000	51,200,000	50,100,000	53,500,000	52,700,000	51,500,000	50,100,000	41,800,000	40,200,000	38,595,435	37,344,891
Shares (Diluted)	56,700,000	53,000,000	51,200,000	50,100,000	54,100,000	53,800,000	52,400,000	51,400,000	50,300,000	49,300,000	47,255,842	45,802,807
EBITDA	$196M	$100.0K	$-601M	$-170M	$353M	$484M	$164M	$126M	$157M	$134M	$121M	$81M

Bilanço 30

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$205M	$100M	$112M	$643M	$576M	$621M	$168M	$112M	$178M	$272M	$313M	$280M
Receivables	$84M	$154M	$191M	$159M	$279M	$231M	$271M	$262M	$144M	$138M	$114M	$59M
Inventory	$343M	$312M	$329M	$351M	$344M	$307M	$222M	$206M	$143M	$74M	$61M	$66M
Prepaid Expense	$26M	$27M	$48M	$58M	$70M	$36M	$25M	$32M	$17M	$16M	$18M	$24M
Current Assets	$662M	$599M	$680M	$1.21B	$1.27B	$1.20B	$686M	$621M	$485M	$510M	$537M	$432M
PP&E (Net)	$205M	$271M	$383M	$818M	$800M	$644M	$542M	$510M	$407M	$376M	$328M	$314M
PP&E (Gross)	$510M	$668M	$794M	$1.20B	$1.12B	$903M	$753M	$682M	$540M	$488M	$422M	$393M
Accum. Depreciation	$304M	$397M	$411M	$384M	$319M	$259M	$210M	$172M	$132M	$112M	$94M	$79M
Goodwill	$0	$0	$0	$218M	$225M	$267M	$267M	$260M	$49M	$41M	$41M	$53M
Intangibles	$436M	$502M	$567M	$729M	$605M	$663M	$713M	$762M	$120M	$34M	$41M	$58M
Other Non-current Assets	$14M	$19M	$194M	$191M	$58M	$113M	$90M	$14M	$6M	$2M	$2M	$8M
Total Assets	$1.32B	$1.39B	$1.82B	$3.17B	$2.96B	$2.88B	$2.33B	$2.23B	$1.07B	$970M	$1.04B	$939M
Accounts Payable	$56M	$61M	$112M	$104M	$129M	$136M	$95M	$81M	$42M	$35M	$38M	$41M
Accrued Liabilities	$12M	$18M	$19M	$35M	$52M	$47M	$40M	$31M	$5M	$6M	$6M	$6M
Short-term Debt	·	$0	$414M	$957M	$32M	$34M	$13M	$10M	$0	$20M	$0	·
Current Liabilities	$132M	$162M	$651M	$1.23B	$374M	$384M	$216M	$200M	$100M	$106M	$100M	$93M
Capital Leases	$9M	$10M	$14M	$15M	$24M	$28M	$22M	·	·	·	·	·
Deferred Tax	$38M	$42M	$47M	$60M	$93M	$53M	$64M	$68M	$0	·	·	·
Other Non-current Liabilities	$54M	$39M	$29M	$42M	$70M	$68M	$49M	$49M	$5M	$2M	$1M	$1M
Total Liabilities	$796M	$907M	$1.17B	$1.78B	$1.35B	$1.44B	$1.24B	$1.22B	$158M	$374M	$377M	$385M
Long-term Debt	$590M	$700M	$868M	$1.41B	$850M	$886M	$822M	$809M	$14M	·	·	·
Total Debt	$572M	$664M	$1.27B	·	$873M	$909M	$824M	$805M	$13M	$268M	$253M	$251M
Common Stock	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$41.0K	$40.0K	$38.0K
Paid-in Capital	$942M	$928M	$904M	$874M	$829M	$785M	$716M	$689M	$618M	$352M	$318M	$274M
Retained Earnings	$-160M	$-212M	$-22M	$739M	$950M	$727M	$422M	$367M	$337M	$254M	$351M	$288M
Treasury Stock	$253M	$228M	$228M	$228M	$152M	$40M	$40M	$40M	$40M	$6M	$6M	$6M
AOCI	$-8M	$-5M	$-6M	$3M	$-16M	$-25M	$-10M	$-6M	$-4M	$-4M	$-3M	$-3M
Stockholders' Equity	$523M	$483M	$649M	$1.39B	$1.61B	$1.45B	$1.09B	$1.01B	$912M	$596M	$660M	$553M
Liabilities + Equity	$1.32B	$1.39B	$1.82B	$3.17B	$2.96B	$2.88B	$2.33B	$2.23B	$1.07B	$970M	$1.04B	$939M
Shares Outstanding	52,100,000	54,300,000	52,200,000	50,100,000	51,300,000	54,300,000	51,700,000	51,200,000	49,400,000	41,000,000	39,800,000	38,129,872

Nakit Akışı 19

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$96M	$109M	$125M	$143M	$124M	$50M	$50M	$36M	$32M	$28M	$24M	$22M
Stock-based Comp	$16M	$18M	$23M	$45M	$42M	$52M	$27M	$23M	$15M	$18M	$16M	$13M
Deferred Tax	$-4M	$-6M	$-7M	$-34M	$43M	$-3M	$-1M	$9M	$3M	$5M	$3M	$16M
Amort. of Intangibles	$65M	$65M	$66M	$60M	$58M	$60M	$59M	$25M	$9M	$7M	$7M	$7M
Restructuring	$-2M	$22M	$29M	·	·	·	·	·	·	·	·	$0
Other Non-cash	$10M	$128M	$413M	·	·	$132M	$58M	$-89M	$75M	$-50M	$-62M	$23M
Operating Cash Flow	$171M	$59M	$-206M	$-34M	$320M	$537M	$188M	$42M	$208M	$55M	$43M	$112M
CapEx	$14M	$23M	$52M	$116M	$224M	$142M	$87M	$72M	$55M	$76M	$45M	$31M
Investing Cash Flow	$69M	$125M	$212M	$-381M	$-224M	$-152M	$-97M	$-897M	$-250M	$-76M	$-45M	$-210M
Debt Issued	·	·	·	·	·	·	·	$798M	$0	$0	$2M	$1M
Net Debt Issued	·	·	·	·	·	·	·	$795M	$0	$0	$0	$-62M
Stock Issued	$0	$0	$8M	$0	$0	·	·	·	·	·	·	·
Stock Repurchased	$25M	$0	$0	$82M	$106M	$0	$0	$100.0K	$33M	$0	$100.0K	$200.0K
Net Stock Activity	$-25M	$0	$8M	$-82M	$-106M	$0	$0	$-100.0K	$-33M	$0	$-100.0K	$-200.0K
Financing Cash Flow	$-137M	$-190M	$-536M	$481M	$-141M	$70M	$-36M	$789M	$-51M	$-20M	$35M	$199M
Net Change in Cash	$104M	$-6M	$-531M	$66M	$-45M	$454M	$56M	$-67M	$-93M	$-41M	$32M	$101M
Taxes Paid	$40M	·	·	·	·	·	·	·	·	·	·	·
Free Cash Flow	$157M	$36M	$-258M	$-150M	$96M	$395M	$101M	$-30M	$153M	$-23M	$-353.0K	$82M
Levered FCF	·	·	$-349M	$-186M	$71M	$372M	$74M	$-38M	$149M	$-28M	$-5M	$76M

Kârlılık 8

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	·	·	30.3%	34.3%	·	·	·	·	·	·	·	·
Operating Margin	13.5%	-10.4%	-69.2%	-15.2%	19.7%	27.9%	10.3%	11.5%	22.2%	21.6%	18.4%	12.9%
Net Margin	7.1%	-18.3%	-72.5%	-18.9%	12.9%	19.6%	4.9%	8.0%	14.7%	10.6%	12.0%	8.2%
Pretax Margin	11.2%	-13.7%	-69.7%	-19.6%	17.5%	26.2%	7.0%	10.4%	21.1%	20.3%	17.2%	11.8%
EBITDA Margin	26.4%	0.01%	-57.3%	-15.2%	19.7%	31.1%	14.8%	16.1%	27.9%	27.3%	23.1%	18.0%
ROA	3.9%	-11.9%	-30.5%	·	7.9%	11.7%	2.4%	3.8%	8.1%	5.2%	6.4%	4.7%
ROE	9.9%	-38.5%	-113.0%	·	14.7%	22.6%	5.1%	6.3%	10.9%	8.2%	10.4%	7.0%
ROIC	5.8%	-12.7%	-39.3%	·	10.4%	13.8%	4.2%	3.8%	9.3%	7.7%	7.4%	5.0%

Likidite ve Solventlik 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	5.0	3.7	1.0	·	3.4	3.1	3.2	3.1	4.9	4.8	5.4	4.7
Quick Ratio	2.2	1.6	0.5	·	2.3	2.2	2.0	1.9	3.2	3.9	4.4	3.7
Debt / Equity	1.1	1.4	2.0	·	0.5	0.6	0.8	0.8	0.0	0.4	0.4	0.5
LT Debt / Equity	1.1	1.4	0.7	·	0.5	0.6	0.7	0.8	0.0	0.4	0.4	0.5
Interest Coverage	·	·	-8.3	-4.6	10.2	13.9	3.0	9.1	18.9	13.9	14.7	7.0

Verimlilik 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.6	0.4	·	0.6	0.6	0.5	0.5	0.5	0.5	0.5	0.6
Inventory Turnover	1.0	·	2.1	·	·	2.0	2.0	1.8	1.8	1.9	1.7	2.9
Receivables Turnover	6.2	6.0	6.0	·	7.1	6.2	4.1	3.9	4.0	3.9	5.8	7.5

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$10.03	$8.89	$12.44	·	$31.56	$27.25	$21.05	$19.74	$18.47	$14.69	$16.75	$14.67
Revenue / Share	$13.10	$19.69	$20.49	$22.31	$33.14	$28.91	$21.11	$15.22	$11.14	$9.91	$11.06	$9.83
Cash Flow / Share	$3.01	$1.11	$-4.03	$-0.68	$5.94	$9.96	$3.59	$0.81	$4.14	$1.08	$0.94	$2.45
Cash / Share	$3.94	$1.83	$2.14	·	$11.23	$11.70	$3.25	$2.19	$3.61	$6.69	$7.94	$7.44
EPS (TTM)	$0.93	$-3.60	$-14.85	$-4.22	$4.06	$5.68	$1.04	$1.22	$1.71	$1.13	$1.41	$0.88

Büyüme Oranları 7

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-28.8%	-0.54%	-6.1%	-37.0%	12.4%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-12.7%	-16.2%	-12.7%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-14.0%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	·	·	·	·	-28.5%	·	·	·	·	·	·	·
EPS CAGR 5Y	-30.4%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	·	·	·	·	-28.2%	·	·	·	·	·	·	·
Net Income CAGR 5Y	-29.7%	·	·	·	·	·	·	·	·	·	·	·

Değerleme (TTM) 14

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$743M	$1.04B	$1.05B	$1.12B	$1.77B	$1.58B	$1.11B	$782M	$561M	$489M	$489M	$404M
Net Income TTM	$53M	$-191M	$-760M	$-212M	$220M	$306M	$54M	$63M	$83M	$52M	$63M	$37M
Market Cap	$644M	$519M	$125M	·	$2.23B	$4.76B	$2.79B	$3.04B	$2.30B	$1.33B	$1.58B	$1.03B
Enterprise Value	$1.01B	$1.08B	$1.29B	·	$2.53B	$5.05B	$3.45B	$3.73B	$2.13B	$1.33B	$1.52B	$997M
P/E	13.3	-2.7	-0.2	-2.8	10.7	15.8	51.9	48.6	27.2	29.1	28.4	30.9
P/S	0.9	0.5	0.1	·	1.3	3.0	2.5	3.9	4.1	2.7	3.2	2.5
P/B	1.2	1.1	0.2	·	1.4	3.3	2.6	3.0	2.5	2.2	2.4	1.9
P / Tangible Book	7.5	·	1.5	1.3	2.9	9.1	·	·	·	·	·	·
P / Cash Flow	3.8	8.8	-0.6	·	6.9	8.9	14.8	72.6	11.0	24.9	35.5	9.1
P / FCF	4.1	14.5	-0.5	·	23.2	12.0	27.6	-100.2	15.0	-58.5	-4466.5	12.6
EV / EBITDA	5.2	10833.1	-2.1	·	7.2	10.4	21.1	29.6	13.6	10.0	12.6	12.3
EV / FCF	6.4	30.3	-5.0	·	26.3	12.8	34.1	-123.0	13.9	-58.4	-4297.1	12.2
EV / Revenue	1.4	1.0	1.2	·	1.4	3.2	3.1	4.8	3.8	2.7	3.1	2.5
Earnings Yield	7.5%	-37.7%	-618.8%	-35.7%	9.3%	6.3%	1.9%	2.1%	3.7%	3.4%	3.5%	3.2%

Gelir Tablosu 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$234M	$156M	$149M	$231M	$141M	$222M	$195M	$294M	$255M	$300M	$277M	$270M	$338M	$164M	$330M	$240M
Cost of Revenue	$97M	$72M	$85M	$86M	$67M	$88M	$118M	$123M	$296M	$145M	$185M	$177M	$191M	$153M	·	$147M
Gross Profit	·	·	·	·	·	·	·	$161M	$-48M	$148M	·	$87M	$141M	$5M	·	$75M
R&D Expense	$9M	$10M	$12M	$14M	$12M	$15M	$9M	$14M	$33M	$15M	$29M	$15M	$26M	$41M	$50M	$42M
SG&A Expense	$45M	$47M	$51M	$39M	$44M	$52M	$61M	$77M	$86M	$85M	$90M	$86M	$91M	$101M	$92M	$82M
Operating Income	$-125M	$10M	$-28M	$76M	$2M	$50M	$-10M	$64M	$-204M	$40M	$-44M	$-242M	$-293M	$-148M	$-55M	$-45M
Interest Expense	·	·	·	·	·	·	·	·	·	$24M	·	$20M	$29M	$18M	·	$8M
Other Non-op	$0	$14M	$-8M	$-4M	$-4M	$70M	$-4M	$22M	$-3M	$-3M	$8M	$-3M	$-4M	$5M	$7M	$-13M
Pretax Income	$-166M	$13M	$-51M	$58M	$-17M	$93M	$-28M	$142M	$-270M	$12M	$-54M	$-266M	$-250M	$-161M	$-65M	$-67M
Income Tax	$14M	$7M	$4M	$6M	$-5M	$25M	$4M	$28M	$13M	$3M	$-5M	$-2M	$11M	$26M	$-800.0K	$20M
Net Income	$-180M	$7M	$-55M	$51M	$-12M	$68M	$-31M	$115M	$-283M	$9M	$-50M	$-263M	$-261M	$-186M	$-67M	$-87M
EPS (Basic)	$-3.49	$0.13	$-1.01	$0.96	$-0.22	$1.25	$-0.55	$2.16	$-5.38	$0.17	$-0.90	$-5.08	$-5.16	$-3.71	$-1.32	$-1.75
EPS (Diluted)	$-3.49	$0.07	$-0.95	$0.91	$-0.22	$1.19	$-0.45	$2.06	$-5.38	$0.17	$-0.90	$-5.08	$-5.16	$-3.71	$-1.32	$-1.75
Shares (Basic)	51,600,000	51,900,000	·	53,200,000	54,200,000	54,400,000	·	53,100,000	52,600,000	52,200,000	·	51,800,000	50,700,000	50,200,000	·	49,900,000
Shares (Diluted)	51,600,000	56,500,000	·	56,500,000	54,200,000	57,300,000	·	55,600,000	52,600,000	52,200,000	·	51,800,000	50,700,000	50,200,000	·	49,900,000
EBITDA	$-125M	$34M	·	$76M	$2M	$75M	·	$64M	$-204M	$68M	·	$-242M	$-293M	$-114M	·	$-42M

Bilanço 30

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$140M	$160M	$205M	$246M	$267M	$149M	$100M	$150M	$70M	$78M	$112M	$88M	$89M	$430M	$643M	$241M
Receivables	$190M	$122M	$84M	$150M	$80M	$204M	$154M	$121M	$196M	$234M	·	$216M	$290M	$156M	·	$191M
Inventory	$304M	$328M	$343M	$356M	$339M	$314M	$312M	$323M	$318M	$333M	·	$354M	$354M	$368M	·	$546M
Prepaid Expense	$25M	$27M	$26M	$26M	$24M	$30M	$27M	$61M	$36M	$36M	·	$62M	$45M	$42M	·	$140M
Current Assets	$666M	$638M	$662M	$787M	$720M	$707M	$599M	$661M	$654M	$682M	·	$721M	$778M	$1.22B	·	$1.12B
PP&E (Net)	$178M	$199M	$205M	$210M	$216M	$221M	$271M	$278M	$306M	$379M	·	$395M	$396M	$717M	·	$807M
PP&E (Gross)	$475M	$509M	$510M	$500M	$516M	$518M	$668M	$672M	$707M	$802M	·	$796M	$787M	$1.09B	·	$1.17B
Accum. Depreciation	$297M	$310M	$304M	$291M	$300M	$297M	$397M	$394M	$401M	$423M	·	$401M	$391M	$375M	·	$366M
Goodwill	·	·	$0	·	·	·	$0	$0	$0	$0	$0	$0	$218M	$218M	·	$225M
Intangibles	$262M	$470M	$436M	$453M	$469M	$485M	$502M	$518M	$534M	$550M	·	$583M	$593M	$609M	·	$723M
Other Non-current Assets	$11M	$13M	$14M	$12M	$12M	$13M	$19M	$20M	$19M	$191M	·	$194M	$195M	$185M	·	$36M
Total Assets	$1.12B	$1.32B	$1.32B	$1.46B	$1.42B	$1.43B	$1.39B	$1.48B	$1.51B	$1.80B	·	$1.89B	$2.18B	$2.95B	·	$2.91B
Accounts Payable	$50M	$40M	$56M	$57M	$64M	$58M	$61M	$82M	$96M	$100M	·	$113M	$108M	$124M	·	$104M
Accrued Liabilities	$17M	$9M	$12M	$14M	$14M	$13M	$18M	$16M	$17M	$14M	·	$17M	$31M	$21M	·	$36M
Short-term Debt	·	·	·	·	·	·	·	$800.0K	$415M	$459M	·	$414M	$455M	$951M	·	$21M
Current Liabilities	$123M	$149M	$132M	$136M	$127M	$112M	$162M	$230M	$620M	$630M	·	$664M	$693M	$1.22B	·	$268M
Capital Leases	$5M	$9M	$9M	$6M	$6M	$5M	$10M	$11M	$12M	$13M	·	$15M	$13M	$13M	·	$16M
Deferred Tax	$35M	$33M	$38M	$36M	$46M	$60M	$42M	$42M	$35M	$35M	·	$52M	$58M	$60M	·	$114M
Other Non-current Liabilities	$35M	$42M	$54M	$43M	$40M	$35M	$39M	$36M	$26M	$28M	·	$31M	$23M	$24M	·	$45M
Total Liabilities	$775M	$797M	$796M	$878M	$881M	$873M	$907M	$969M	$1.13B	$1.14B	·	$1.20B	$1.22B	$1.75B	·	$1.46B
Long-term Debt	$590M	$590M	$590M	$693M	$700M	$700M	$700M	$701M	$864M	$909M	·	$866M	$909M	$1.41B	·	$1.06B
Total Debt	$582M	$574M	·	$663M	$668M	$666M	·	$663M	$1.28B	$1.37B	·	$1.28B	$1.36B	$2.35B	·	$1.07B
Common Stock	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	·	$100.0K	$100.0K	$100.0K	·	$100.0K
Paid-in Capital	$952M	$944M	$942M	$939M	$935M	$931M	$928M	$924M	$915M	$910M	·	$900M	$896M	$878M	·	$860M
Retained Earnings	$-333M	$-153M	$-160M	$-105M	$-156M	$-144M	$-212M	$-181M	$-296M	$-13M	·	$28M	$290M	$551M	·	$822M
Treasury Stock	$270M	$262M	$253M	$244M	$235M	$228M	$228M	$228M	$228M	$228M	·	$228M	$228M	$228M	·	$228M
AOCI	$-7M	$-7M	$-8M	$-8M	$-8M	$-6M	$-5M	$-7M	$-6M	$-6M	·	$-3M	$-2M	$1M	·	$-5M
Stockholders' Equity	$341M	$523M	$523M	$582M	$536M	$553M	$483M	$508M	$386M	$664M	$649M	$697M	$956M	$1.20B	$1.39B	$1.45B
Liabilities + Equity	$1.12B	$1.32B	$1.32B	$1.46B	$1.42B	$1.43B	$1.39B	$1.48B	$1.51B	$1.80B	·	$1.89B	$2.18B	$2.95B	·	$2.91B
Shares Outstanding	51,300,000	51,800,000	52,100,000	52,700,000	53,700,000	54,500,000	54,300,000	54,100,000	52,900,000	52,400,000	·	51,800,000	51,800,000	50,400,000	·	49,900,000

Nakit Akışı 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$24M	$24M	$24M	$23M	$24M	$25M	$26M	$26M	$28M	$28M	$30M	$28M	$33M	$35M	$36M	$32M
Stock-based Comp	$7M	$2M	$5M	$5M	$5M	$2M	$4M	$2M	$6M	$6M	$4M	$4M	$8M	$7M	$12M	$11M
Deferred Tax	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$-57M	$20M
Amort. of Intangibles	$17M	$16M	$16M	$16M	$16M	$16M	$16M	$16M	$16M	$16M	$16M	$16M	$16M	$17M	$18M	$14M
Restructuring	·	·	$0	$300.0K	$-1M	$-1M	$-400.0K	$6M	$17M	$-500.0K	$-600.0K	$20M	$-100.0K	$10M	·	·
Other Non-cash	·	$-66M	·	·	·	$-106M	·	·	·	$-105M	·	·	·	$-42M	·	·
Operating Cash Flow	$56M	$-34M	$78M	$-2M	$106M	$-11M	$-80M	$154M	$48M	$-63M	$32M	$60M	$-114M	$-184M	$93M	$-74M
CapEx	$2M	$2M	$4M	$3M	$3M	$4M	$2M	$6M	$5M	$11M	$11M	$13M	$12M	$15M	$24M	$28M
Investing Cash Flow	$-52M	$-2M	$-4M	$-3M	$17M	$60M	$29M	$112M	$-5M	$-11M	$-11M	$-19M	$258M	$-15M	$-45M	$-272M
Stock Issued	·	$400.0K	$-1M	·	·	$0	$0	$0	·	·	$200.0K	$0	·	·	$0	$0
Stock Repurchased	$9M	$9M	$9M	$9M	$7M	$0	$0	$0	·	·	$0	$0	$0	$0	$200.0K	$0
Net Stock Activity	·	$-9M	·	·	·	·	·	·	·	·	·	·	·	$0	·	·
Financing Cash Flow	$-24M	$-11M	$-114M	$-16M	$-6M	$-400.0K	$500.0K	$-180M	$-51M	$41M	$5M	$-43M	$-487M	$-10M	$353M	$229M
Net Change in Cash	$-21M	$-48M	$-40M	$-22M	$118M	$47M	$-51M	$85M	$-8M	$-33M	$24M	$-800.0K	$-344M	$-210M	$402M	$-117M
Free Cash Flow	·	$-36M	·	·	·	$-15M	·	·	·	$-73M	·	·	·	$-199M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-91M	·	·	·	$-219M	·	·

Kârlılık 8

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	·	·	·	·	·	·	·	54.9%	-18.9%	49.2%	·	32.2%	41.6%	2.1%	·	30.8%
Operating Margin	-53.4%	6.7%	·	33.1%	1.1%	22.5%	·	21.9%	-79.9%	13.2%	·	-89.5%	-86.7%	-89.7%	·	-17.5%
Net Margin	-76.9%	4.4%	·	22.1%	-8.5%	30.6%	·	39.1%	-111.1%	3.0%	·	-97.4%	-77.3%	-110.8%	·	-31.5%
Pretax Margin	-71.0%	8.6%	·	24.9%	-11.9%	41.7%	·	48.5%	-105.9%	4.0%	·	-98.3%	-74.1%	-97.6%	·	-26.6%
EBITDA Margin	-53.4%	21.8%	·	33.1%	1.1%	33.9%	·	21.9%	-79.9%	22.5%	·	-89.5%	-86.7%	-68.8%	·	-17.5%
ROA	-14.2%	0.50%	·	3.5%	-0.82%	4.2%	·	6.8%	-15.3%	0.38%	·	-11.0%	-10.6%	-6.4%	·	-2.6%
ROE	-41.1%	1.3%	·	9.4%	-2.6%	11.2%	·	19.0%	-42.2%	0.96%	·	-24.5%	-21.2%	-13.2%	·	-5.1%
ROIC	-14.7%	0.49%	·	5.5%	0.09%	3.0%	·	4.4%	-12.8%	1.5%	·	-12.2%	-13.2%	-4.7%	·	-2.0%

Likidite ve Solventlik 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	5.4	4.3	·	5.8	5.7	6.3	·	2.9	1.1	1.1	·	1.1	1.1	1.0	·	4.2
Quick Ratio	2.7	1.9	·	2.9	2.7	3.2	·	1.2	0.4	0.5	·	0.5	0.5	0.5	·	1.6
Debt / Equity	1.7	1.1	·	1.1	1.2	1.2	·	1.3	3.3	2.1	·	1.8	1.4	2.0	·	0.7
LT Debt / Equity	1.7	1.1	·	1.1	1.2	1.2	·	1.3	1.2	0.7	·	0.6	0.5	0.4	·	0.7
Interest Coverage	·	·	·	·	·	·	·	·	·	1.6	·	-12.3	-10.2	-8.3	·	-4.9

Verimlilik 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.2	0.1	·	0.2	0.1	0.1	·	0.2	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	0.3	0.2	·	0.3	0.2	0.3	·	0.4	0.9	0.4	·	0.4	0.5	0.4	·	·
Receivables Turnover	1.7	1.0	·	1.7	1.0	1.0	·	1.7	1.0	1.5	·	1.3	1.5	1.0	·	1.1

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$6.66	$10.10	·	$11.05	$9.99	$10.14	·	$9.40	$7.30	$12.67	·	$13.46	$18.46	$23.86	·	$29.04
Revenue / Share	$4.54	$2.76	·	$4.09	$2.60	$3.88	·	$5.28	$4.84	$5.75	·	$5.22	$6.66	$3.29	·	$4.81
Cash Flow / Share	·	$-0.60	·	·	·	$-0.20	·	·	·	$-1.20	·	·	·	$-3.67	·	·
Cash / Share	$2.72	$3.09	·	$4.66	$4.98	$2.74	·	$2.77	$1.32	$1.50	·	$1.70	$1.71	$8.54	·	$4.83
EPS (TTM)	$-3.46	$-0.19	·	$1.43	$2.58	$-2.58	·	$-4.05	$-11.19	$-10.97	·	$-15.27	$-11.94	$-7.84	·	$0.40

Değerleme (TTM) 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$770M	$677M	·	$789M	$852M	$965M	·	$1.13B	$1.10B	$1.19B	·	$1.10B	$1.07B	$977M	·	$1.49B
Net Income TTM	$-177M	$-9M	·	$76M	$140M	$-132M	·	$-209M	$-587M	$-565M	·	$-778M	$-602M	$-393M	·	$33M
Market Cap	$430M	$430M	·	$465M	$343M	$265M	·	$452M	$361M	$133M	·	$176M	$381M	$522M	·	$1.05B
Enterprise Value	$872M	$843M	·	$882M	$743M	$781M	·	$965M	$1.57B	$1.42B	·	$1.36B	$1.65B	$2.44B	·	$1.88B
P/E	-2.4	-43.7	·	6.2	2.5	-1.9	·	-2.1	-0.6	-0.2	·	-0.2	-0.6	-1.3	·	52.5
P/S	0.6	0.6	·	0.6	0.4	0.3	·	0.4	0.3	0.1	·	0.2	0.4	0.5	·	0.7
P/B	1.3	0.8	·	0.8	0.6	0.5	·	0.9	0.9	0.2	·	0.3	0.4	0.4	·	0.7
P / Tangible Book	5.4	8.2	·	3.6	5.1	3.9	·	·	·	1.2	·	1.5	2.6	1.4	·	2.1
P / Cash Flow	·	-12.7	·	·	·	-23.6	·	·	·	-2.1	·	·	·	-2.8	·	·
EV / Revenue	1.1	1.2	·	1.1	0.9	0.8	·	0.9	1.4	1.2	·	1.2	1.5	2.5	·	1.3
Earnings Yield	-41.3%	-2.3%	·	16.2%	40.4%	-53.1%	·	-48.5%	-164.1%	-433.6%	·	-449.1%	-162.5%	-75.7%	·	1.9%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2022-09-30
Gelir	$743M	$1.04B	$1.05B	$1.12B	·
Brüt Kâr Marjı %	·	·	30.3%	34.3%	·
Faaliyet Kâr Marjı %	13.5%	-10.4%	-69.2%	-15.2%	·
Net Gelir	$53M	$-191M	$-760M	$-212M	·
Seyreltilmiş Hisse Başı Kâr	$0.93	$-3.60	$-14.85	$-4.22	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2022-09-30
Borç / Öz Sermaye	1.1	1.4	2.0	·	·
Cari Oran	5.0	3.7	1.0	·	·
Cari Oran	2.2	1.6	0.5	·	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2022-09-30
Serbest Nakit Akışı	$157M	$36M	$-258M	$-150M	·

Kurumsal Sahipler (13F) 209 dosya · $391.0M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 209

Tutulan Değer $391.0M

Yeni pozisyonlar 31

Çıkan pozisyonlar 24

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
31 (-7 önceki Ç'ye göre)	24 (+1 önceki Ç'ye göre)	71 (+1 önceki Ç'ye göre)	63 (+9 önceki Ç'ye göre)	+916K

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
VANGUARD GROUP INC	$43.927.428	3.553.999	11,23%	Hisse senetleri
BlackRock, Inc.	$39.525.100	4.716.599	10,11%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$25.782.865	3.076.646	6,59%	Hisse senetleri
STATE STREET CORP	$24.556.367	2.929.238	6,28%	Hisse senetleri
AMERICAN CENTURY COMPANIES INC	$23.216.354	2.770.448	5,94%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$18.426.271	2.198.839	4,71%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$11.208.910	1.337.243	2,87%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$10.062.629	1.200.791	2,57%	Hisse senetleri
OAK HILL ADVISORS LP	$9.329.772	1.113.338	2,39%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$8.984.910	1.072.185	2,30%	Hisse senetleri
AQR CAPITAL MANAGEMENT LLC	$8.724.846	1.041.151	2,23%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$8.676.828	1.035.421	2,22%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$8.626.129	1.029.371	2,21%	Hisse senetleri
D. E. Shaw & Co., Inc.	$7.542.905	900.108	1,93%	Hisse senetleri
Russell Investments Group, Ltd.	$7.202.462	859.482	1,84%	Hisse senetleri
FEDERATED HERMES, INC.	$6.964.828	831.125	1,78%	Hisse senetleri
PRUDENTIAL FINANCIAL INC	$6.753.400	805.895	1,73%	Hisse senetleri
Prescott Group Capital Management, L.L.C.	$6.475.821	772.771	1,66%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$5.725.610	683.247	1,46%	Hisse senetleri
NORTHERN TRUST CORP	$5.207.944	621.473	1,33%	Hisse senetleri
Allianz Asset Management GmbH	$4.556.885	543.781	1,17%	Hisse senetleri
PALISADE CAPITAL MANAGEMENT, LP	$4.316.191	515.059	1,10%	Hisse senetleri
NEW YORK STATE COMMON RETIREMENT FUND	$4.306.516	513.904	1,10%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$4.091.820	488.284	1,05%	Hisse senetleri
MORGAN STANLEY	$3.936.225	469.715	1,01%	Hisse senetleri
Prosight Management, LP	$3.854.398	459.952	0,99%	Hisse senetleri
Trexquant Investment LP	$3.753.050	447.858	0,96%	Hisse senetleri
O'SHAUGHNESSY ASSET MANAGEMENT, LLC	$3.690.745	440.423	0,94%	Hisse senetleri
UBS Group AG	$3.067.172	366.011	0,78%	Hisse senetleri
Connor, Clark & Lunn Investment Management Ltd.	$2.966.378	353.983	0,76%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$2.863.614	341.720	0,73%	Hisse senetleri
PANAGORA ASSET MANAGEMENT INC	$2.757.523	329.060	0,71%	Hisse senetleri
Values First Advisors, Inc.	$2.526.468	301.488	0,65%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$2.420.144	288.800	0,62%	Alım opsiyonu
GLOBEFLEX CAPITAL L P	$2.022.077	241.298	0,52%	Hisse senetleri
Bank of New York Mellon Corp	$1.840.760	219.661	0,47%	Hisse senetleri
FMR LLC	$1.794.733	214.169	0,46%	Hisse senetleri
Brandywine Global Investment Management, LLC	$1.610.632	130.310	0,41%	Hisse senetleri
DEUTSCHE BANK AG\	$1.591.513	189.918	0,41%	Hisse senetleri
Morse Asset Management, Inc	$1.536.339	183.334	0,39%	Hisse senetleri
WOLVERINE ASSET MANAGEMENT LLC	$1.465.939	174.933	0,37%	Hisse senetleri
FRANKLIN RESOURCES INC	$1.398.144	166.843	0,36%	Hisse senetleri
Y-Intercept (Hong Kong) Ltd	$1.390.066	165.879	0,36%	Hisse senetleri
ARISTEIA CAPITAL, L.L.C.	$1.355.490	161.753	0,35%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$1.275.596	152.219	0,33%	Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP	$1.273.476	151.966	0,33%	Hisse senetleri
Squarepoint Ops LLC	$1.240.374	148.016	0,32%	Hisse senetleri
CREDIT AGRICOLE S A	$1.225.994	146.300	0,31%	Hisse senetleri
Invesco Ltd.	$1.224.024	146.065	0,31%	Hisse senetleri
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$1.028.000	122.700	0,26%	Hisse senetleri

Tüm 209 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 1 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Emergent BioSolutions Inc.	23 Ağustos 2010	·	İlk başvuru	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 48 içeriden öğrenenler · 12 yöneticiler · 11 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Daniel Abdun-Nabi	CEO	04 Mart 2019 S	142.617	0	$0
Richard S Lindahl	EVP, Chief Financial Officer	08 Haziran 2026 F	374.083	0	$0
Don R Elsey	Chief Financial Officer	13 Mart 2012 A	26.614	0	$0
Paul Anthony Williams	SVP, Products Business	01 Temmuz 2026 S	159.098	2	$-58.960
William Hartzel	SVP, Bioservices	08 Haziran 2026 F	185.558	0	$0
Coleen Glessner	EVP, Quality & Ethics, and CPL	08 Haziran 2026 F	202.201	1	$-306.080
Simon C Lowry	SVP, R&D, CMO	29 Nisan 2026 A	177.914	0	$0
Jessica Perl	SVP, General Counsel, Corp Sec	29 Nisan 2026 A	165.286	0	$0
Barry Labinger	EVP, Biosciences Div.	13 Kasım 2015 S	25.182	0	$0
Steven Chatfield	EVP, BioSciences	14 Mart 2013 F	28.000	0	$0
Kyle Keese	EVP, BioSciences Division	15 Mart 2011 A	18.759	0	$0
Stephen Lockhart	SVP Product Development	11 Kasım 2010 M	6.980	0	$0
Kathryn C Zoon	Yönetim kurulu üyesi	30 Nisan 2026 A	79.941	2	$-144.453
Donald W Degolyer	Yönetim kurulu üyesi	30 Nisan 2026 A	129.721	3	$-317.617
Sujata Tyagi Dayal	Yönetim kurulu üyesi	30 Nisan 2026 A	100.563	3	$-201.130
Neal Franklin Fowler	Yönetim kurulu üyesi	30 Nisan 2026 A	160.847	0	$0
Marvin L White	Yönetim kurulu üyesi	30 Nisan 2026 A	113.839	0	$0
John D Fowler JR	Yönetim kurulu üyesi	30 Nisan 2026 A	30.350	0	$0
Fuad El-Hibri	Yönetim kurulu üyesi	03 Aralık 2021 J	206.434	0	$0
Seamus Mulligan	Yönetim kurulu üyesi	19 Mart 2019 A	56.141	0	$0
John Niederhuber	Yönetim kurulu üyesi	18 Mayıs 2016 D	30.300	0	$0
Shahzad Malik	Yönetim kurulu üyesi	14 Haziran 2007 A	·	0	$0
Intervac, L.L.C.	10% sahip	18 Eylül 2012 J	4.344.250	0	$0
BioPharm, L.L.C.	10% sahip	27 Mayıs 2010 J	2.265.043	0	$0
Microscience Investments LTD	10% sahip	08 Mart 2007 J	0	0	$0
Zsolt Harsanyi	·	30 Nisan 2026 A	149.076	0	$0
Ronald Richard	·	30 Nisan 2026 A	123.761	2	$-263.101
Keith Katkin	·	30 Nisan 2026 A	96.294	1	$-128.183
Joseph C Papa	·	29 Nisan 2026 A	493.153	0	$0
Louis W Sullivan	·	30 Nisan 2025 A	139.098	0	$0
Jennifer Lynne Fox	·	11 Temmuz 2024 A	186.382	0	$0
Adam Havey	·	09 Haziran 2023 A	174.398	0	$0
Robert Kramer	·	09 Haziran 2023 A	506.059	0	$0
Jerome M Hauer	·	25 Mayıs 2023 A	57.508	0	$0
Katherine Strei	·	28 Şubat 2023 F	62.824	0	$0
Atul Saran	·	28 Şubat 2023 F	86.645	0	$0
George A Joulwan	·	26 Mayıs 2022 A	40.244	0	$0
Karen L. Smith	·	07 Mayıs 2021 F	11.888	0	$0
Sean Kirk	·	31 Mart 2021 F	17.776	0	$0
Sue Bailey	·	04 Mart 2021 S	24.427	0	$0
Denise Esposito	·	10 Mart 2009 A	500	0	$0
Biologika, L.L.C.	·	04 Haziran 2008 S	1.399.764	0	$0
Joe M Allbaugh	·	21 Mayıs 2008 A	·	0	$0
Michigan Biologic Products, Inc.	·	28 Mart 2008 S	1.269.390	0	$0
Mauro Gibellini	·	04 Haziran 2007 S	0	0	$0
Thomas Zink	·	17 Mayıs 2007 P	1.000	0	$0
Edward Arcuri	·	08 Mayıs 2007 M	76.722	0	$0
Robert Calvin Myers	·	20 Kasım 2006 C	·	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 61 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
EWO · iShares, Inc.	23,05%	335.709 SH	11 Eylül 2026	Günlük
EUFN · iShares Trust	1,19%	353.714 SH	11 Eylül 2026	Günlük
MTRA · Invesco Actively Managed Exchange-T…	1,14%	11.292 SH	01 Ekim 2026	Günlük
MYLD · Cambria ETF Trust	0,87%	41.046 NS	31 Temmuz 2026	N-PORT
PIZ · Invesco Exchange-Traded Fund Trust …	0,69%	33.118 SH	01 Ekim 2026	Günlük
EZU · iShares, Inc.	0,57%	390.787 SH	11 Eylül 2026	Günlük
BSJS · Invesco Exchange-Traded Self-Indexe…	0,40%	3.381.000	01 Ekim 2026	Günlük
DMXF · iShares Trust	0,40%	26.552 SH	11 Eylül 2026	Günlük
IEV · iShares Trust	0,32%	37.421 SH	11 Eylül 2026	Günlük
IVLU · iShares Trust	0,31%	102.055 SH	11 Eylül 2026	Günlük
IXG · iShares Trust	0,28%	13.907 SH	11 Eylül 2026	Günlük
IEUR · iShares Trust	0,28%	179.129 SH	11 Eylül 2026	Günlük
IMTM · iShares Trust	0,25%	77.739 SH	11 Eylül 2026	Günlük
VGK · VANGUARD INTERNATIONAL EQUITY INDEX…	0,24%	673.051 SH	19 Ağustos 2026	Günlük
PABD · iShares Trust	0,23%	5.313 SH	11 Eylül 2026	Günlük
EFG · iShares Trust	0,20%	236.854 SH	11 Eylül 2026	Günlük
VYMI · VANGUARD WHITEHALL FUNDS	0,20%	312.634 SH	19 Ağustos 2026	Günlük
EFA · iShares Trust	0,20%	1.097.211 SH	11 Eylül 2026	Günlük
EFV · iShares Trust	0,20%	436.714 SH	11 Eylül 2026	Günlük
IEFA · iShares Trust	0,17%	2.312.794 SH	11 Eylül 2026	Günlük
IDEV · iShares Trust	0,15%	343.523 SH	11 Eylül 2026	Günlük
ESGD · iShares Trust	0,14%	123.676 SH	11 Eylül 2026	Günlük
ACWX · iShares Trust	0,12%	101.401 SH	11 Eylül 2026	Günlük
PXF · Invesco Exchange-Traded Fund Trust …	0,11%	23.661 SH	01 Ekim 2026	Günlük
VEA · VANGUARD TAX-MANAGED FUNDS	0,11%	2.737.509 SH	19 Ağustos 2026	Günlük
VSGX · VANGUARD WORLD FUND	0,11%	56.354 SH	19 Ağustos 2026	Günlük
IXUS · iShares Trust	0,10%	431.754 SH	11 Eylül 2026	Günlük
VEU · VANGUARD INTERNATIONAL EQUITY INDEX…	0,09%	655.464 SH	19 Ağustos 2026	Günlük
LABU · Direxion Shares ETF Trust	0,08%	57.978 NS	31 Temmuz 2026	N-PORT
VXUS · VANGUARD STAR FUNDS	0,08%	4.120.164 SH	19 Ağustos 2026	Günlük
IWC · iShares Trust	0,07%	175.885 SH	11 Eylül 2026	Günlük
TOK · iShares Trust	0,05%	841 SH	11 Eylül 2026	Günlük
URTH · iShares, Inc.	0,05%	28.175 SH	11 Eylül 2026	Günlük
ACWI · iShares Trust	0,04%	100.105 SH	11 Eylül 2026	Günlük
IMFL · Invesco Exchange-Traded Self-Indexe…	0,04%	2.979 SH	01 Ekim 2026	Günlük
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,03%	242.129 SH	19 Ağustos 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	45.382 SH	19 Ağustos 2026	Günlük
DFSV · Dimensional ETF Trust	0,03%	304.251 NS	31 Temmuz 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	105.903 SH	01 Ekim 2026	Günlük
PWS · Pacer Funds Trust	0,02%	792 NS	31 Temmuz 2026	N-PORT
IBB · iShares Trust	0,02%	366.188 SH	11 Eylül 2026	Günlük
DFAT · Dimensional ETF Trust	0,02%	374.907 NS	31 Temmuz 2026	N-PORT
CRBN · iShares Trust	0,02%	1.504 SH	11 Eylül 2026	Günlük
RSSL · Global X Funds	0,01%	24.878 NS	31 Temmuz 2026	N-PORT
IWM · iShares Trust	0,01%	1.357.340 SH	11 Eylül 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	299.394 SH	19 Ağustos 2026	Günlük
VHT · VANGUARD WORLD FUND	0,01%	151.590 SH	19 Ağustos 2026	Günlük
DFAS · Dimensional ETF Trust	0,01%	170.332 NS	31 Temmuz 2026	N-PORT
DXUV · Dimensional ETF Trust	0,00%	2.757 NS	31 Temmuz 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	140.649 NS	31 Temmuz 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	5.377 NS	31 Temmuz 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	2.661 NS	31 Temmuz 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	18.981 NS	31 Temmuz 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	10.026 NS	31 Temmuz 2026	N-PORT
ITOT · iShares Trust	0,00%	56.305 SH	11 Eylül 2026	Günlük
IWV · iShares Trust	0,00%	14.557 SH	04 Eylül 2026	Günlük
VXF · VANGUARD INDEX FUNDS	0,00%	592.580 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	1.554.116 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	4.439 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	499.316 SH	11 Eylül 2026	Günlük
SMLF · iShares Trust	·	279.031 SH	11 Eylül 2026	Günlük

EBS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 7 analist AL

Medyan hedef $11.00 +73,8%

1 14,3% Güçlü Al

4 57,1% Al

1 14,3% Tut

1 14,3% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

2 analist · 2026-09-28

Ortalama hedef $11.00 +73,8%

← Tüm hedeflerin altında Mevcut fiyat $6.33

Düşük$10.00 Ortalama$11.00 Yüksek$12.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
EBS	$644M	13.3	-28.8%	7.1%	9.9%	·
SRZN	·	·	·	·	·	·
CYPH	$97M	16.6	·	·	6.1%	·
ARTV	·	-1.3	-99.2%	·	·	·
SCTX	·	·	·	·	·	·
BNTC	$460M	-13.7	·	·	-25.0%	·
BBOT	$1.00B	-2.9	·	·	-146.2%	·
CABA	$220M	-1.0	·	·	-115.5%	·
LRMR	$317M	-2.2	·	·	-167.4%	·

Son Haberler Bu şirketten bahseden son manşetler

23

"Termal Olay" Kuzey Virginia'daki Amazon AWS Bulut Merkezi'nde Hizmet Kesintilerine Neden Oldu ZeroHedge · 4 ay, 3 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

EBS Emergent BioSolutions Inc. Common Stock

EBS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

EBS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Kurumsal Sahipler (13F) 209 dosya · $391.0M toplam · Tarih itibarıyla 30 Haziran 2026

Aktivistler ve %5+ sahipler 1 pozisyon

Şirket yöneticileri 48 içeriden öğrenenler · 12 yöneticiler · 11 yönetim kurulu üyeleri

ETF sahipliği 61 ETF'ler tarafından tutuluyor

EBS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Son Haberler Bu şirketten bahseden son manşetler

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar